The FDA has approved Pfizer’s RSV vaccine for older adults, the second such shot approved for the common virus
Earlier in May, the agency approved the world’s first RSV vaccine for older adults, made by GSK. The vaccines could be available for seniors by fall, pending recommendations from the US Centers for Disease Control and Prevention and its vaccine advisers, who are scheduled to meet in June. Respiratory syncytial virus, known as RSV, is a highly contagious virus that causes flu-like illness in people of all ages.
7% effective at preventing moderated lower respiratory tract illness with two or more symptoms and 85.7% effective at preventing illness with three or more symptoms in people 60 and older, according to Pfizer. Members of the FDA’s Vaccines and Related Biological Products Advisory Committee voted 7-4 with one abstention in February that there was adequate data to support the vaccine’s safety and effectiveness.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer gets FDA approval for RSV vaccine Abrysvo in older adultsPfizer Inc. said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug...
Baca lebih lajut »
FDA approves Pfizer RSV vaccine for older adultsThe approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a similar shot made by GSK.
Baca lebih lajut »
New Pfizer RSV Vaccine Rolls Out Into Headwinds of HesitancyNew vaccines for the deadly virus RSV are rolling out—and more vaccines for other infectious diseases are on the way—even though many Americans soured on shots during the Covid pandemic
Baca lebih lajut »
FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss | CNNThe US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Baca lebih lajut »
When courts challenge the FDA’s authority, they put patients’ lives at riskThe entire biotechnology and pharmaceutical industry will be thrown into turmoil if judges can second-guess the scientific expertise of the US Food and Drug Administration.
Baca lebih lajut »
‘Exciting Time’: FDA Commissioner Talks AI and MisinformationShould we be worried about AI's growing influence in healthcare, and what can the FDA do about the Adderall shortage? WebMD Chief Medical Officer drjohnwhyte sat down with US_FDA Commissioner Dr. Robert M. Califf to talk about this and more. Watch here:
Baca lebih lajut »